In the inaugural episode of Berry's "In the Interim...," we sit down with the founders of Berry Consultants, Dr. Don Berry and Dr. Scott Berry. Celebrating their 25th anniversary as a company, they explore the pioneering journey of their firm, known for transforming the landscape of clinical trials with their adaptive and Bayesian methodologies. With stories from their early days to innovative projects on the horizon, this episode provides a fascinating look into how Berry Consultants is redefining clinical research and impacting global health.
Key Highlights
- The founding story of Berry Consultants and the inspiration behind their unique approach to clinical trials.
- Challenges faced in pioneering adaptive trials and overcoming regulatory hurdles.
- Key collaborations and the influence of FDA approvals in their adaptive trial designs.
- The revolutionary impact of platform trials developed by Berry Consultants during the COVID pandemic.
- Future innovations and aspirations for the next 25 years in clinical trial design.
Quotes
- "We really were providing the service that they didn’t know they needed." – Dr. Don Berry
- "Our methodology allows the client to be the biggest advocate for the direction they're going." – Dr. Scott Berry
- "We want to change the world, one person at a time." – Dr. Don Berry
